Spinal Muscular Atrophy News and Research

RSS
Spinal muscular atrophy (SMA) is a motor neuron disease and the leading genetic cause of death among infants and toddlers. Characterized by selective loss of nerve cells in the spinal cord, the disease leads to increasing muscular weakness and atrophy. Over time, patients afflicted by SMA continue to lose muscle control and strength, leading to progressive inability to walk, stand, sit up and breathe. It is estimated that approximately 1 in 6,000 to 1 in 10,000 infants are born annually worldwide with SMA.
Spinal Muscular Atrophy Foundation and BG Medicine collaborate

Spinal Muscular Atrophy Foundation and BG Medicine collaborate

New biotech company develops UD-patented technologies for repairing genes

New biotech company develops UD-patented technologies for repairing genes

European network launched to aid muscle disease patients

European network launched to aid muscle disease patients

Whoever said people were much the same was wrong!

Whoever said people were much the same was wrong!

New approaches to genetic disease, based on cells' own ability to correct themselves

New approaches to genetic disease, based on cells' own ability to correct themselves

Parents win high court battle to keep their baby alive

Parents win high court battle to keep their baby alive

Neurological and neuromuscular diseases raise risk of complications from flu

Neurological and neuromuscular diseases raise risk of complications from flu

Overall genome landscape between chimps and humans can be attributed to large segmental duplications

Overall genome landscape between chimps and humans can be attributed to large segmental duplications

Exposing SMA-affected cells to aminoglycoside drugs can increase SMN

Exposing SMA-affected cells to aminoglycoside drugs can increase SMN

Indoprofen may lead to new treatments for spinal muscular atrophy

Indoprofen may lead to new treatments for spinal muscular atrophy